Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial
Recruiting now · Not applicable
Conditions studied: Stroke
In brief
The goal of this multisite clinal trial is to evaluate the implementation of the home-based Graded Repetitive Arm Supplementary Program (GRASP) at rehabilitation clinics across several hospitals. The main questions it aims to answer is: • the efficacy of the home-based GRASP program relative to the conventional occupational therapy intervention on improving health outcomes, including UE motor function, daily function, quality of life, and motor control strategies. Stroke participants will be randomly assigned to either the Home-based GRASP group or the conventional occupational therapy home program group. Each group will undergo an 4 to 6-week intervention (3 sessions/week) with evaluations conducted before, immediately after, and 3 months post-trial, assessing clinical and kinematic measures. Interviews and surveys will be conducted to gain insights into the perspectives of patients regarding the implementation of the home-based GRASP program.
Key facts
- Study ID
- NCT06204744
- Run by
- Chang Gung Memorial Hospital
- People needed
- 143
- Starts
- 2023-09-08
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2024-01-12
Who can join
Age: 20 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- are aged 20 years or older
- have upper extremity hemiparesis due to the first-ever stroke
- have some voluntary movement in the affected UE
- are able to follow 2-step instructions
You may not qualify if…
- orthopedic conditions affecting the arm/hand or other neurological conditions
- severe pain that prevents movement in the affected arm and hand
- unstable medical status
Where it is running
- Chiayi Chang Gung Memorial Hospital — Chiayi City, Taiwan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.